Search Results - "Haller Julia, A"

Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion by Haller, Julia A., MD, Bandello, Francesco, MD, Belfort, Rubens, MD, Blumenkranz, Mark S., MD, Gillies, Mark, MD, Heier, Jeffrey, MD, Loewenstein, Anat, MD, Yoon, Young-Hee, MD, Jacques, Marie-Louise, MD, Jiao, Jenny, PhD, Li, Xiao-Yan, MD, Whitcup, Scott M., MD

“…Objective To evaluate the safety and efficacy of dexamethasone intravitreal implant (DEX implant; OZURDEX, Allergan, Inc., Irvine, CA) compared with sham in…”
Get full text

Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind by Ho, Allen C., MD, Humayun, Mark S., MD, PhD, Dorn, Jessy D., PhD, da Cruz, Lyndon, MD, Dagnelie, Gislin, PhD, Handa, James, MD, Barale, Pierre-Olivier, MD, Sahel, José-Alain, MD, Stanga, Paulo E., MD, Hafezi, Farhad, MD, PhD, Safran, Avinoam B., MD, Salzmann, Joel, MD, Santos, Arturo, MD, PhD, Birch, David, PhD, Spencer, Rand, MD, Cideciyan, Artur V., PhD, de Juan, Eugene, MD, Duncan, Jacque L., MD, Eliott, Dean, MD, Fawzi, Amani, MD, Olmos de Koo, Lisa C., MD, Brown, Gary C., MD, Haller, Julia A., MD, Regillo, Carl D., MD, Del Priore, Lucian V., MD, Arditi, Aries, PhD, Geruschat, Duane R., PhD, Greenberg, Robert J., MD, PhD

“…Purpose Retinitis pigmentosa (RP) is a group of inherited retinal degenerations leading to blindness due to photoreceptor loss. Retinitis pigmentosa is a rare…”
Get full text

Intravitreal Aflibercept Injection for Macular Edema Due to Central Retinal Vein Occlusion by Heier, Jeffrey S., MD, Clark, W. Lloyd, MD, Boyer, David S., MD, Brown, David M., MD, Vitti, Robert, MD, Berliner, Alyson J., MD, PhD, Kazmi, Husain, MD, Ma, Yu, PhD, Stemper, Brigitte, MD, Zeitz, Oliver, MD, Sandbrink, Rupert, MD, PhD, Haller, Julia A., MD

“…Purpose To evaluate the efficacy and safety of intravitreal aflibercept injection (IAI) for the treatment of macular edema secondary to central retinal vein…”
Get full text

Exploring the Associated Genetic Causes of Diabetic Retinopathy as a Model of Inflammation in Retinal Diseases by Cappellani, Francesco, Regillo, Carl D, Haller, Julia A, Gagliano, Caterina, Pulido, Jose S

“…To investigate potential biomarkers and biological processes associated with diabetic retinopathy (DR) using transcriptomic and proteomic data. The OmicsPred…”
Get full text

Outcomes and Risk Factors Associated with Endophthalmitis after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents by Shah, Chirag P., MD, MPH, Garg, Sunir J., MD, Vander, James F., MD, Brown, Gary C., MD, MBA, Kaiser, Richard S., MD, Haller, Julia A., MD

“…Objective To describe outcomes of and risk factors for endophthalmitis after intravitreal anti–vascular endothelial growth factor (VEGF) injection. Design…”
Get full text

Efficacy of Intravitreal Ocriplasmin for Treatment of Vitreomacular Adhesion by Haller, Julia A., MD, Stalmans, Peter, MD, PhD, Benz, Matthew S., MD, Gandorfer, Arnd, MD, Pakola, Stephen J., MD, Girach, Aniz, MD, Kampik, Anselm, MD, Jaffe, Glenn J., MD, Toth, Cynthia A., MD

“…Purpose To evaluate the efficacy of a single intravitreal injection of ocriplasmin 125 μg across relevant subpopulations of patients with symptomatic…”
Get full text

A Placebo-Controlled Trial of Microplasmin Intravitreous Injection to Facilitate Posterior Vitreous Detachment before Vitrectomy by Benz, Matthew S., MD, Packo, Kirk H., MD, Gonzalez, Victor, MD, Pakola, Stephen, MD, Bezner, Donna, Haller, Julia A., MD, Schwartz, Steven D., MD

“…Purpose To evaluate the safety and efficacy of a preoperative intravitreous injection of microplasmin in patients scheduled for vitreous surgery. Design Phase…”
Get full text

Vascular Endothelial Growth Factor Is a Critical Stimulus for Diabetic Macular Edema by Nguyen, Quan Dong, Tatlipinar, Sinan, Shah, Syed Mahmood, Haller, Julia A., Quinlan, Edward, Sung, Jennifer, Zimmer-Galler, Ingrid, Do, Diana V., Campochiaro, Peter A.

“…The role of vascular endothelial growth factor (VEGF) in diabetic macular edema (DME) was tested with ranibizumab, a specific antagonist of VEGF. A…”
Get full text

A salute to Team Shields by Haller, Julia

“…At Notre Dame, she performed with remarkable distinction in the classroom and on the basketball court, where she was one of the inaugural founders of Notre…”
Get full text

Retinal Thickness Analysis by Race, Gender, and Age Using Stratus OCT by Kashani, Amir H, Zimmer-Galler, Ingrid E, Shah, Syed Mahmood, Dustin, Laurie, Do, Diana V, Eliott, Dean, Haller, Julia A, Nguyen, Quan Dong

“…Purpose To detect differences in retinal thickness among patients of different race, gender, and age using Stratus OCT. Design Cross-sectional study. Methods…”
Get full text

Effect of the Duration of Macular Edema on Clinical Outcomes in Retinal Vein Occlusion Treated with Dexamethasone Intravitreal Implant by Yeh, Wei-Shi, PhD, Haller, Julia A., MD, Lanzetta, Paolo, MD, Kuppermann, Baruch D., MD, PhD, Wong, Tien Yin, MD, PhD, Mitchell, Paul, MD, PhD, Whitcup, Scott M., MD, Kowalski, Jonathan W., PharmD, MS

“…Purpose To assess the effect of duration of macular edema (ME) on clinical outcomes after treatment with dexamethasone intravitreal implant 0.7 mg (Ozurdex;…”
Get full text

Delayed Intraocular Foreign Body Removal without Endophthalmitis during Operations Iraqi Freedom and Enduring Freedom by Colyer, Marcus H., MD, Weber, Eric D., MD, Weichel, Eric D., MD, Dick, John S.B., MD, Bower, Kraig S., MD, Ward, Thomas P., MD, Haller, Julia A., MD

“…Objective To report the long-term follow-up results of intraocular foreign body (IOFB) removal at Walter Reed Army Medical Center during Operation Iraqi…”
Get full text

Pepper Spray, Tear Gas, and Rubber Bullets: A Witches' Brew of Toil and Trouble by Haller, Julia A

Get more information

Age, Gender, and Laterality of Retinal Vascular Occlusion: A Retrospective Study from the IRIS® Registry by Li, Yangjiani, Hall, Nathan E, Pershing, Suzann, Hyman, Leslie, Haller, Julia A, Lee, Aaron Y, Lee, Cecilia S, Chiang, Michael, Lum, Flora, Miller, Joan W, Lorch, Alice, Elze, Tobias

“…Retinal vascular occlusion is a leading cause of profound irreversible visual loss, but the understanding of the disease is insufficient. We systematically…”
Get more information

Strengthened ties between industry and academia are historical, productive, and crucial by Haller, Julia A., MD

“…Abstract Scientific collaboration between academia and industry has a long history in the United States and abroad. Initially U.S. companies took…”
Get full text

Clock Is Still Ticking on Stop-the-Clock Policies by Haller, Julia A

Get more information

Effect of the SARS-CoV-2 Pandemic on Authorship Gender Disparities in the Ophthalmology Literature by Kalavar, Meghana, Watane, Arjun, Iyer, Prashanth, Cavuoto, Kara M, Haller, Julia A, Sridhar, Jayanth

“…Studies in several fields of medicine have found that women published less during the COVID-19 pandemic, potentially due to an increase in domestic…”
Get full text

Current anti-vascular endothelial growth factor dosing regimens: benefits and burden by Haller, Julia A

“…To examine the outcomes of clinical trials and case studies that investigated the different dosing regimens used for the 3 intravitreal anti-vascular…”
Get full text

A Randomized, Dose-Escalation Study of Subconjunctival and Intravitreal Injections of Sirolimus in Patients with Diabetic Macular Edema by Dugel, Pravin U., MD, Blumenkranz, Mark S., MD, Haller, Julia A., MD, Williams, George A., MD, Solley, Wayne A., MD, Kleinman, David M., MD, Naor, Joel, MD

“…Objective To evaluate the safety and tolerability of a single subconjunctival (SCJ) or intravitreal (IVT) injection of an ophthalmic sirolimus formulation in…”
Get full text

Ten-year Follow-Up of a Subretinal Silicon Prosthesis for Retinitis Pigmentosa by Khan, M. Ali, MD, Ho, Allen C., MD, Haller, Julia A., MD

Get full text